Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 23 Dec 2024

Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

in Vaccines and Molecular Therapeutics

Yang Gong
Hongbin Jia
Wenrui Dang
Ting Zhou
Pu He
Xiaolei Wang
Bingdong Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490003

2,226 views

Original Research

Published on 23 Dec 2024

Immunogenicity of the CoronaVac vaccine in children: a real-world study

in Vaccines and Molecular Therapeutics

Wbeimar Aguilar-Jimenez
Ana Lucia Rodriguez-Perea
Mateo Chvatal-Medina
Paula A. Velilla
Wildeman Zapata-Builes
Laura M. Monsalve-Escudero
Maria I. Zapata-Cardona
Jorge Humberto Tabares-Guevara
Daniel S. Rincón
Juan C. Hernandez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504935

1,532 views

Review

Published on 20 Dec 2024

A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action

in Vaccines and Molecular Therapeutics

Sabine Arve-Butler
Cody Deumont Moorman

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494499

4,990 views
1 citation

Brief Research Report

Published on 20 Dec 2024

Association of the immunogenicity of intramuscular SARS-CoV-2 mRNA vaccination with computed tomography muscle images in patients with muscular disorders

in Vaccines and Molecular Therapeutics

Tomoaki Naka
Michinori Funato
Kunihiko Yasuda
Takahiro Nakayama
Satoshi Kuru

Frontiers in Immunology

doi 10.3389/fimmu.2024.1479321

1,142 views

Systematic Review

Published on 20 Dec 2024

Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: a systematic review

in Vaccines and Molecular Therapeutics

Takele Adugna
Qingli Niu
Guiquan Guan
Junzheng Du
Jifei Yang
Zhancheng Tian
Hong Yin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1505612

3,265 views

Original Research

Published on 20 Dec 2024

Development of a two-component recombinant vaccine for COVID-19

in Vaccines and Molecular Therapeutics

Yi-Sheng Sun
Fang Xu
Han-Ping Zhu
Yong Xia
Qiao-Min Li
Yuan-Yuan Luo
Hang-Jing Lu
Bei-Bei Wu
Zhen Wang
Ping-Ping Yao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514226

1,931 views

Original Research

Published on 19 Dec 2024

MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity

in Vaccines and Molecular Therapeutics

Ilka Grewe
Monika Friedrich
Marie-Louise Dieck
Michael Spohn
My Linh Ly
Verena Krähling
Leonie Mayer
Sibylle C. Mellinghoff
Monika Rottstegge
Rebekka Kraemer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500615

2,729 views

Original Research

Published on 18 Dec 2024

SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy

in Vaccines and Molecular Therapeutics

Ioana Martac
Sina A. Beer
Aileen Schenk
Osama Ahmad
Claus-Philipp Maier
Gülay Demirel
Beate Preuß
Reinhild Klein
Anna M. P. Stanger
Britta Besemer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1510942

1,955 views

Original Research

Published on 18 Dec 2024

Revitalizing tetanus vaccine literacy post road accidents: a comprehensive examination of knowledge and awareness initiative among non-medical university students in Lahore, Pakistan

in Vaccines and Molecular Therapeutics

Fiza Ayub
Wahaj Saleem
Muhammad Awais Shahid
Muhammad Afzal Hussain Khan
Amal K. Suleiman
Laiba Akram
Sadaf Sajid
Allah Bukhsh
Mirza Rafi Baig
Tahir Mehmood Khan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1468356

1,765 views
1 citation

Brief Research Report

Published on 17 Dec 2024

Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children

in Vaccines and Molecular Therapeutics

Youjia Zhong
Amuthavalli Kottaiswamy
Chen Xiang Ang
Hui’ En Li
Gaik Chin Yap
Carina J. X. Tay
Nurul Elyana Osman
Siti Namirah Binte Roslan
Chee Wah Tan
Wee Chee Yap

Frontiers in Immunology

doi 10.3389/fimmu.2024.1502598

1,856 views

Original Research

Published on 16 Dec 2024

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization

in Vaccines and Molecular Therapeutics

William R. Lykins
Jeroen Pollet
Jessica A. White
Brian Keegan
Leroy Versteeg
Ulrich Strych
Wen-Hsiang Chen
Raodoh Mohamath
Gabi Ramer-Denisoff
Sierra Reed

Frontiers in Immunology

doi 10.3389/fimmu.2024.1480976

2,825 views
1 citation

Review

Published on 13 Dec 2024

Single chain fragment variable, a new theranostic approach for cardiovascular diseases

in Vaccines and Molecular Therapeutics

Rukhshan Zahid
Juncheng Wang
Zecheng Cai
Ayesha Ishtiaq
Meng Liu
Dan Ma
Yan Liang
Yuekang Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443290

1,581 views
1 citation

Editorial

Published on 12 Dec 2024

Editorial: Single-domain antibodies—biology, engineering and emerging applications, volume II

in Vaccines and Molecular Therapeutics

Kevin A. Henry
Greg Hussack
Jan Gettemans
Cory L. Brooks

Frontiers in Immunology

doi 10.3389/fimmu.2024.1537054

1,457 views

Original Research

Published on 11 Dec 2024

Next-generation adjuvant systems containing furfurman drives potent adaptive immunity and host defense as a foot-and-mouth disease vaccine adjuvant

in Vaccines and Molecular Therapeutics

Hyeong Won Kim
Seokwon Shin
So Hui Park
Jong-Hyeon Park
Su-Mi Kim
Yoon-Hee Lee
Min Ja Lee

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491043

2,992 views

Original Research

Published on 11 Dec 2024

Phage-resistance alters Lipid A reactogenicity: a new strategy for LPS-based conjugate vaccines against Salmonella Rissen

in Vaccines and Molecular Therapeutics

Paola Cuomo
Chiara Medaglia
Angela Casillo
Antonio Gentile
Carmine Fruggiero
Maria Michela Corsaro
Rosanna Capparelli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450600

1,557 views

Original Research

Published on 10 Dec 2024

Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies

in Vaccines and Molecular Therapeutics

Nicole L. Jarvi
Manali Patel
Krithika A. Shetty
Nhan H. Nguyen
Brooke F. Grasperge
Donald E. Mager
Robert M. Straubinger
Sathy V. Balu-Iyer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1496169

2,582 views
1 citation